Key result
Mean platelet volume was higher in nSTEACS patients than healthy controls but was not an independent predictor of cardiovascular death or new ACS at 6 months.
Why the study?
Does mean platelet volume (MPV) at admission independently predict cardiovascular death and new ACS at 6 months in patients with nSTEACS?
Observational (n=416)
Does mean platelet volume (MPV) at admission independently predict cardiovascular death and new ACS at 6 months in patients with nSTEACS?
Answers are grounded in this paper and cite their sources.
While mean platelet volume is elevated in patients with nSTEACS compared to healthy controls, it does not serve as an independent prognostic marker for cardiovascular death or recurrent ACS at 6 months.
The aim of this study is to determine mean platelet volume (MPV) in a population with non-ST-elevation acute coronary syndrome (nSTEACS) and explore its relation with prognosis. Patients (n = 329) with a diagnosis of nSTEACS at admission were recruited, with a determination of MPV in the first 12 hours at admission. We also collected blood from 87 healthy controls. A composite end point of cardiovascular death and new ACS was assessed at 6-month follow-up. Patients with nSTEACS showed larger platelets (MPV: 11.0 [10.3-11.8] vs 9.2 [8.6-10.0] fL; P < .001.). In Cox regression analysis, MPV at admission was a significant predictor of cardiovascular adverse events in univariate analysis, hazard ratio (HR) 1.4 95% confidence interval (CI) 1.1-1.8; P = .018; but after adjustment with clinical variables, MPV lost its statistical significance. In conclusion, patients with nSTEACS present with larger platelets than healthy controls, however this parameter did not show an independent prognostic significance at 6-month follow-up.
No takes yet. Share an insight, caveat, or question.
López‐Cuenca et al. (2011) conducted an observational in Non-ST-elevation acute coronary syndrome (nSTEACS) (n=416). Mean platelet volume (MPV) vs. Healthy controls was evaluated on Composite of cardiovascular death and new ACS (HR 1.4, 95% CI 1.1-1.8, p=.018). Mean platelet volume was higher in nSTEACS patients than healthy controls but was not an independent predictor of cardiovascular death or new ACS at 6 months.
Synapse has enriched 10 related papers. Consider them for comparative context: